Category:Highly Useful Treatments: Difference between revisions

From Glioblastoma Treatments
Jump to navigationJump to search
Line 4: Line 4:
{{#ask: [[Has Usefulness Rating::4]] OR [[Has Usefulness Rating::5]]
{{#ask: [[Has Usefulness Rating::4]] OR [[Has Usefulness Rating::5]]
| ?Has treatment name
| ?Has treatment name
| ?Has usefulness rating
| ?Has usefulness_rating
| ?Has toxicity level
| ?Has toxicity level
| format=table
| format=table
}}
}}

Revision as of 10:01, 27 March 2024

Highly Useful Treatments

This page lists all treatments within the wiki that have been rated with a usefulness of 4 or 5, indicating promising or highly effective options based on current research and clinical trials.

 Has treatment nameHas usefulness ratingHas toxicity level
Agenus Prophage (Heat-Shock Protein Peptide Complex-96) VaccineAgenus Prophage (Heat-Shock Protein Peptide Complex-96) Vaccine
AnlotinibAnlotinib
Anti-CMV Dendritic Cell VaccineAnti-CMV Dendritic Cell Vaccine
BCNU (Carmustine) and Gliadel (Carmustine Wafers)BCNU (Carmustine) and Gliadel (Carmustine Wafers)
Bevacizumab (Avastin)Bevacizumab (Avastin)
CBDCBD (Cannabidiol)
CCNU (Lomustine)CCNU (Lomustine)
CannabisCannabis and Cannabis-derived Products (e.g., Sativex)
ChloroquineChloroquine and Hydroxychloroquine
ChronotherapyChronotherapy with Temozolomide (TMZ)
Dendritic Cell Vaccine (DCVax-L)Dendritic Cell Vaccine (DCVax-L)
Fish oilFish Oil (Omega-3 Fatty Acids: EPA and DHA)
HyperthermiaHyperthermia
ICT-107ICT-107 (Tumor-associated Antigen Vaccine)
KeppraKeppra (Levetiracetam)
MelatoninMelatonin
Metronomic low dose temozolomide (TMZ)Metronomic Low-Dose Temozolomide (TMZ)
Next-Generation CAR T-Cell Therapy for GBMNext-Generation CAR T-Cell Therapy for GBM
OptuneOptune (Optune Gio® for newer version)
Proton Radiation TherapyProton Beam Therapy (PBT)
SL-701SL-701 (Immunotherapy Vaccine)
SativexSativex (Nabiximols)
VT-122VT-122 (Propranolol and Etodolac combination)
Vitamin DVitamin D
Wilms Tumor 1 (WT1) Peptide VaccineWilms Tumor Peptide Vaccine

This category currently contains no pages or media.